Table 2.

Relations between systemic symptomatology, ocular history and ocular involvement during COVID-19 acute phase

Systemic symptomatology and history	OR (IC 95)	p
Influenza-like illness	1,10 (1,02 – 1,19)	0.0163 *
Pulmonary	1,15 (1,04 – 1,28)	0.0173 *
Neurological	1,18 (1,02 – 1,65)	0.0355 *
Digestive	1,31 (1,04 – 1,65)	0.0340 *
Need for mechanical ventilation	0,68 (0,35 – 1,32)	0.2489
Comorbidities	0,90 (0,72 – 1,13)	0.3822
Anti-inflammatory drugs	0,75 (0,45 – 1,25)	0.2917
Ocular history
Infectious conjunctivitis	1,35 (1,04 – 1,76)	0.0355 *
Allergic conjunctivitis	1,65 (1,13 – 2,39)	0.0151 *
Dry eye disease	1,27 (0,94 – 1,71)	0.1342
Other ocular disease	1,11 (0,64 – 1,90)	0.7173
History of eye surgery	0,86 (0,43 – 1,73)	0.6767
Contact lenses wear	0,89 (0,48 – 1,69)	0.7392
Spectacles wear	0,97 (0,86 – 1,08)	0.5469

* p < 0.05. All of the systemic manifestations of COVID-19 were statistically associated with occurrence of ocular symptoms. Previous infectious conjunctivitis and ocular allergy were correlated with the presence of ocular symptoms